Literature DB >> 24496913

Current use of methylprednisolone for acute spinal cord injury in Poland: survey study.

Grzegorz Miekisiak1, Wojciech Kloc, Witold Janusz, Jacek Kaczmarczyk, Dariusz Latka, Daniel Zarzycki.   

Abstract

PURPOSE: The controversial practice of methylprednisolone (MP) application in acute spinal cord injury (ASCI) is gradually decreasing. This is a survey study designed to assess the current use of MP in ASCI in Poland.
METHODS: The questionnaire comprised of five questions was distributed among 251 spinal surgeons, members of the Polish Society of Spinal Surgery. One hundred and ten (43.8 %) responded, and data from 108 were included in the study.
RESULTS: Majority of respondents (73.1 %) declared the use of MP in ASCI. Most of them (41.7 %) adhered to the NASCIS II protocol, and 24.1 % rather used the NASCIS III protocol. Predominant rationale for the use of steroids was fear of litigation (36.7 %), 30.4 % declared it is as an institutional standard, nearly one-third believed in the effectiveness of drug in improving neurological outcomes. The subgroup analyses revealed no statistically significant interaction for specialty, age, personal involvement in care and institutional case volume.
CONCLUSIONS: As opposed to the literature data from similar studies performed in other countries, the rate of use of MP in ASCI remains high.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24496913     DOI: 10.1007/s00590-014-1422-3

Source DB:  PubMed          Journal:  Eur J Orthop Surg Traumatol        ISSN: 1633-8065


  15 in total

Review 1.  Pharmacological therapy for acute spinal cord injury.

Authors:  R John Hurlbert; Mark N Hadley; Beverly C Walters; Bizhan Aarabi; Sanjay S Dhall; Daniel E Gelb; Curtis J Rozzelle; Timothy C Ryken; Nicholas Theodore
Journal:  Neurosurgery       Date:  2013-03       Impact factor: 4.654

2.  Methylprednisolone for acute spinal cord injury: an inappropriate standard of care.

Authors:  R J Hurlbert
Journal:  J Neurosurg       Date:  2000-07       Impact factor: 5.115

3.  A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury.

Authors:  W P Coleman; D Benzel; D W Cahill; T Ducker; F Geisler; B Green; M R Gropper; J Goffin; P W Madsen; D J Maiman; S L Ondra; M Rosner; R C Sasso; G R Trost; S Zeidman
Journal:  J Spinal Disord       Date:  2000-06

4.  Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study.

Authors:  M B Bracken; M J Shepard; T R Holford; L Leo-Summers; E F Aldrich; M Fazl; M Fehlings; D L Herr; P W Hitchon; L F Marshall; R P Nockels; V Pascale; P L Perot; J Piepmeier; V K Sonntag; F Wagner; J E Wilberger; H R Winn; W Young
Journal:  JAMA       Date:  1997-05-28       Impact factor: 56.272

5.  Changes in the use of the methylprednisolone protocol for traumatic spinal cord injury in Switzerland.

Authors:  Peter Felleiter; Nicole Müller; Frederik Schumann; Olga Felix; Peter Lierz
Journal:  Spine (Phila Pa 1976)       Date:  2012-05-15       Impact factor: 3.468

6.  Methylprednisolone for acute spinal cord injury: 5-year practice reversal.

Authors:  R John Hurlbert; Mark G Hamilton
Journal:  Can J Neurol Sci       Date:  2008-03       Impact factor: 2.104

7.  Current practice of methylprednisolone administration for acute spinal cord injury in Germany: a national survey.

Authors:  Claudia Druschel; Klaus-Dieter Schaser; Jan M Schwab
Journal:  Spine (Phila Pa 1976)       Date:  2013-05-15       Impact factor: 3.468

8.  Does high dose methylprednisolone sodium succinate really improve neurological status in patient with acute cervical cord injury?: a prospective study about neurological recovery and early complications.

Authors:  Yasuo Ito; Yoshihisa Sugimoto; Masao Tomioka; Nobuo Kai; Masato Tanaka
Journal:  Spine (Phila Pa 1976)       Date:  2009-09-15       Impact factor: 3.468

9.  Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial.

Authors:  Ian Roberts; David Yates; Peter Sandercock; Barbara Farrell; Jonathan Wasserberg; Gabrielle Lomas; Rowland Cottingham; Petr Svoboda; Nigel Brayley; Guy Mazairac; Véronique Laloë; Angeles Muñoz-Sánchez; Miguel Arango; Bennie Hartzenberg; Hussein Khamis; Surakrant Yutthakasemsunt; Edward Komolafe; Fatos Olldashi; Yadram Yadav; Francisco Murillo-Cabezas; Haleema Shakur; Phil Edwards
Journal:  Lancet       Date:  2004 Oct 9-15       Impact factor: 79.321

10.  Mortality and morbidity after high-dose methylprednisolone treatment in patients with acute cervical spinal cord injury: a propensity-matched analysis using a nationwide administrative database.

Authors:  Hirotaka Chikuda; Hideo Yasunaga; Katsushi Takeshita; Hiromasa Horiguchi; Hiroshi Kawaguchi; Kazuhiko Ohe; Kiyohide Fushimi; Sakae Tanaka
Journal:  Emerg Med J       Date:  2013-02-28       Impact factor: 2.740

View more
  7 in total

Review 1.  Mechanism of Neuroprotection Against Experimental Spinal Cord Injury by Riluzole or Methylprednisolone.

Authors:  Cynthia Sámano; Andrea Nistri
Journal:  Neurochem Res       Date:  2017-12-30       Impact factor: 3.996

2.  Quantitative iTRAQ proteomics reveal the proteome profiles of bone marrow mesenchymal stem cells after cocultures with Schwann cells in vitro.

Authors:  Han Ding; Ang Li; Chao Sun; Jianping Zhang; Jun Shang; Haoshuai Tang; Junjin Li; Min Wang; Xiaohong Kong; Zhijian Wei; Shiqing Feng
Journal:  Ann Transl Med       Date:  2022-09

3.  Comparative Study on the Effects of Ceftriaxone and Monocytes on Recovery after Spinal Cord Injury in Rat.

Authors:  Javad Tajkey; Alireza Biglari; Bohlol Habibi Asl; Ali Ramazani; Saeideh Mazloomzadeh
Journal:  Adv Pharm Bull       Date:  2015-06-01

4.  Methylprednisolone for the Treatment of Patients with Acute Spinal Cord Injuries: A Propensity Score-Matched Cohort Study from a Canadian Multi-Center Spinal Cord Injury Registry.

Authors:  Nathan Evaniew; Vanessa K Noonan; Nader Fallah; Brian K Kwon; Carly S Rivers; Henry Ahn; Christopher S Bailey; Sean D Christie; Daryl R Fourney; R John Hurlbert; A G Linassi; Michael G Fehlings; Marcel F Dvorak
Journal:  J Neurotrauma       Date:  2015-07-17       Impact factor: 5.269

Review 5.  Worldwide Steroid Prescription for Acute Spinal Cord Injury.

Authors:  Asdrubal Falavigna; Francine W Quadros; Alisson R Teles; Chung Chek Wong; Giuseppe Barbagallo; Darrel Brodke; Abdulaziz Al-Mutair; K Daniel Riew
Journal:  Global Spine J       Date:  2018-02-11

Review 6.  Methylprednisolone for the Treatment of Patients with Acute Spinal Cord Injuries: A Systematic Review and Meta-Analysis.

Authors:  Nathan Evaniew; Emilie P Belley-Côté; Nader Fallah; Vanessa K Noonan; Carly S Rivers; Marcel F Dvorak
Journal:  J Neurotrauma       Date:  2015-12-15       Impact factor: 5.269

Review 7.  Clinical Neurorestorative Therapeutic Guidelines for Spinal Cord Injury (IANR/CANR version 2019).

Authors:  Hongyun Huang; Wise Young; Stephen Skaper; Lin Chen; Gustavo Moviglia; Hooshang Saberi; Ziad Al-Zoubi; Hari Shanker Sharma; Dafin Muresanu; Alok Sharma; Wagih El Masry; Shiqing Feng
Journal:  J Orthop Translat       Date:  2019-11-11       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.